This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ahmadi, A. Articles by Söderkvist, P. Search for Related Content PubMed PubMed Citation Articles by Ahmadi, A. Articles by Söderkvist, P. Social Bookmarking                         What's this?

Interaction between smoking and glutathione S-transferase polymorphisms in solvent-induced chronic toxic encephalopathy

Division of Cell Biology, Department of Biomedicine and Surgery, Faculty of Health Sciences, University Hospital, S-581 86 Linköping, Sweden, ahmah{at}mcb.liu.se; ahmah{at}ibk.liu.se

Pia Jönsson

Division of Occupational and Environmental Medicine, Department of Health and Environment, Faculty of Health Sciences, University Hospital, S-581 86 Linköping, Sweden

Ulf Flodin

Division of Occupational and Environmental Medicine, Department of Health and Environment, Faculty of Health Sciences, University Hospital, S-581 86 Linköping, Sweden

Peter Söderkvist

Division of Cell Biology, Department of Biomedicine and Surgery, Faculty of Health Sciences, University Hospital, S-581 86 Linköping, Sweden

Exposure to organic solvents is still common in industrial and other work environments, and increases the risk of chronic toxic encephalopathy (CTE). Genetic variation in metabolic enzymes for solvents and other xenobiotics may modify the risk of developing toxic effects. Therefore, we investigated the presence of null genotypes for glutathione S-transferases M1 and T1 (GSTM1, GSTT1) and two genetic polymorphisms of microsomal epoxide hydrolase (mEPHX) in relation to the risk for chronic toxic encephalopathy (CTE) when exposed to solvents and smoking. We genotyped 115 patients who were classified into three categories: CTE (n³/4-56), incipient CTE (n³/4-27) and non-CTE (n³/4-32) patients. DNA was isolated from leucocytes and the GSTM1 and GSTT1 null genotypes were determined by multiplex-polymerase chain reaction. The two polymorphisms of mEPHX were analysed by PCR-RFLP (restriction fragment length polymorphism) based assays. All analyses were performed blindly with regard to both exposure and disease status. An increased binomial regression risk ratio³/4-2.5, 95% confidence interval (CI) 1.5-4.2, of the GSTM1 null genotype for CTE was found in smokers and for the GSTT1 null genotype (binomial regression risk ratio 1.5, 95% CI 1.0-2.0). In nonsmokers, the GSTM1 null genotype did not confer any risk for CTE. None of the studied mEPHX polymorphisms were associated with an increased risk for CTE. We suggest that the GSTM1 null genotype in smokers is a possible risk for solvent-induced CTE.

Key Words: chronic toxic encephalopathy • molecular epidemiology • polymorphism • smoking • solvent exposure

Toxicology and Industrial Health, Vol. 18, No. 6, 289-296 (2002)
DOI: 10.1191/0748233702th152oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Kezic, F. Calkoen, M. A. Wenker, J. J. Jacobs, and M. M Verberk Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy Toxicology and Industrial Health, August 1, 2006; 22(7): 281 - 289. [Abstract] [PDF]

				F D Dick Solvent neurotoxicity. Occup. Environ. Med., March 1, 2006; 63(3): 221 - 6, 179. [Full Text] [PDF]